Excretion profile of opiates in dependent patients in relation to route of administration and type of drug measured in urine with immunoassay

Journal of Analytical Toxicology

Volumn 29, Issue 1, 2005, Pages 15-21

  Taracha, Ewa ^a   Habrat, Bogusław ^a   Chmielewska, Karina ^a   Baran Furga, Helena ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BETA N ACETYLHEXOSAMINIDASE; BILIRUBIN; CREATININE; DIAMORPHINE; OPIATE; STREET DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DRUG DETOXIFICATION; DRUG ELIMINATION; DRUG EXCRETION; DRUG URINE LEVEL; FLUORESCENCE POLARIZATION IMMUNOASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; URINE VOLUME;

PAPAVER;

EID: 12344316919     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/29.1.15     Document Type: Article

References (31)

1. E.J. Cone and S.L. Dickerson. Efficacy of urine analysis in monitoring heroin and cocaine abuse patterns: implications in clinical trials for treatment of drug dependence. In Statistical Issues in Clinical Trials for Treatment of Opiate Dependence. NIDA Research Monograph 128, NIDA, Rockville, MD, 1992, pp 46-63.
2. R.J. Harford and H.D. Kleber. Comparative validity of random-interval and fixed-interval urinalysis schedules. Arch. Gen. Psychiatry 35: 356-359 (1978).
3. B. Kilpatrick, M. Howlett, P. Sedgwick, and A.M. Ghodse. Drug use, self report and urinalysis. Drug Alcohol Depend. 58: 111-116 (2000).
4. R.H. Schwartz. Urine testing in the detection of drug of abuse. Arch. Intern. Med. 148: 2407-2412 (1988).
5. K. Silverman, C.J. Wong, S.T. Higgins, R.K. Brooner, I.D. Montoya, C. Contoreggi, A. Umbricht-Schneiter, C.R. Schuster, and K.L. Preston. Increasing opiate abstinence through voucher-based reinforcement therapy. Drug Alcohol Depend. 41: 157-165 (1996).
6. D. Simpson, J. Greenwood, D.R. Jarvie, and P.M. Moore. Experience of a laboratory service for drug screening in urine. Scott Med. J. 38: 20-26 (1993).
7. United Nations International Drug Control Programme. Recommended Methods for the Detection and Assay of Heroin and Cannabinoids in Biological Specimens. Manual for Use by National Laboratories. United Nations, New York, NY, 1993.
8. United Nations International Drug Control Programme. Rapid Testing Methods of Drugs of Abuse. Manual for Use by National Law Enforcement and Narcotics Laboratory Personnel. United Nations, Vienna, Austria, 1994.
9. M. Vandevenne, H. Vandenbussche, and A. Verstraete. Detection time of drugs of abuse in urine. Acta Clin. Belg. 55: 323-333 (2000).
10. E.J. Cone, B.A. Holicky, T.M. Grant, W.D. Darwin, and B.A. Goldberger. Pharmacokinetics and pharmacodynamics of intranasal "snorted" heroin. J. Anal. Toxicol. 17: 327-337 (1993).
11. E.J. Cone. Recent discoveries in pharmacokinetics of drug of abuse. Toxicol. Lett. 102-103: 97-101 (1998).
12. M.L. Smith, E.T. Shimomura, J. Summers, and B.D. Paul. Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin. J. Anal. Toxicol. 25: 504-514 (2001).
13. R.E. Aderjan and G. Skopp. Formation and clearance of active and inactive metabolites of opiates in humans. Ther. Drug Monit. 20: 561-569 (1998).
14. M.L. Smith, E.T. Shimomura, J. Summers, and B.D. Paul. Detection times and analytical performance of commercial urine opiate immunoassays following heroin administration. J. Anal. Toxicol. 24: 522-529 (2000).
15. P.K. Janicki, W.A. Erskine, and M.F. James. The route of prolonged ' morphine administration affects the pattern of its metabolites in the urine of chronically treated patients. Eur. J. Clin. Chem. Clin. Biochem. 29: 391-393 (1991).
16. A. Reiter, J. Hake, C. Meissner, J. Rohwer, H.J. Friedrich, and M. Oehmichen. Time of drug elimination in chronic drug abusers. Case studies of 52 patients in a "low-step" detoxification ward. Forensic. Sci. Int. 119: 248-253 (2001).
17. P. Narongchai, P. Sribanditmonkol, S. Thampithug, S. Narongchai, and C. Chitivuthikarn. The duration time of urine morphine detection in heroin addicts by radioimmunoassay. J. Med. Assoc. Thai. 85: 82-86 (2002).
18. World Health Organization. ICD-10. The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic criteria for research. WHO, Geneva, Switzerland, 1993.
19. M. Kala. Toxicological Analysis of Drugs of Abuse. Institute of Forensic Research Publishers, Kraków, Poland, 2000.
20. M. Kala and W. Lechowicz. Polish the "kompot" and other opiate containing products. A comparative study. Proceedings of the 35th Meeting of TIAFT. Centre of Behavioral and Forensic Toxicology, Padova, Italy, 1997, pp 521-532.
21. Statistica for Windows 6.0. Stat Soft, Inc., Tulsa, OK. (Polish branch Stat Soft Polska, Kraków).
22. C. Meadway, S. George, and R. Braithwaite. Opiate concentration following the ingestion of poppy seed products - evidence for "the poppy seed defence". Forensic Sci. Int. 96: 29-38 (1998).
23. D.C. Fuller. A statistical approach to the prediction of verifiable heroin use from total codeine and total morphine concentrations in urine. J. Forensic Sci. 42: 685-689 (1997).
24. P. Lafolie, O. Beck, Z. Lin, F. Albertioni, and L. Boreus. Urine and plasma pharmacokinetics of codeine in healthy volunteers: implications for drug-of-abuse testing. J. Anal. Toxicol. 20: 541-546 (1996).
25. C.L. O'Neal and A. Poklis. An evaluation of the role of ROC plots in the prediction of heroin use from total codeine and total morphine concentrations in urine. J. Anal. Toxicol. 22: 487-492 (1998).
26. M.J. Bogusz, R.D. Maier, and S. Driessen. Morphine, morphine-3- glucuronide, morphine-6-glucuronide, and 6-monoacetylmorphine determined by means of atmospheric pressure chemical ionization-mass spectrometry liquid chromatography in body fluids of heroin victims. J. Anal. Toxicol. 21: 346-355 (1997).
27. M.J. Bogusz, R.D. Maier, M. Erkens, and S. Driessen. Determination of morphine and its 3- and 6-monoacetylmorphine in body fluids by liquid chromatography atmospheric pressure chemical ionization mass spectrometry. J. Chromatogr. B 703: 115-127 (1997).
28. D. Bourquin, T. Lehmann, R. Hämmig, M. Bührer, and R. Brenneisen. High-performance liquid chromatographic monitoring of intravenously administered diacetylmorphine and morphine and their metabolites in human plasma. J. Chromatogr. B 694: 233-238 (1997).
29. F. Pragst, K. Spiegel, U. Leuschner, and A. Hager. Detection of 6-acety I morphine in vitreous humor and cerebrospinal fluid-comparison with urinary analysis of proving heroin administration in opiate fatalities. J. Anal. Toxicol. 23: 168-172 (1999).
30. M.J. Tabernero, A.M. Bermejo, and P. Fernandez. Analysis of heroin and cocaine by RIA and GC-MS: distribution of their metabolites in urine and hair from drug addicts. Addiction Biol. 4: 421-428 (1999).
31. M.A. Huestis and E.J. Cone. Differentiating new marijuana use from residual drug excretion in occasional marijuana users. J. Anal. Toxicol. 22: 445-454 (1998).